Single-use Digital Hysteroscope (GYUT-A 12.6- 0, GYUT-A12.6- 12, GYUT-A 12.6- 22, GYUT-A 12.6- 30, GYUT-A 14.4- 0, GYUT-A 14.4- 12,GYUT-A 14.4- 22, GYUT-A 14.4- 30, GYUT-B 15- 0, GYUT-B 15- 12, GYUT-B 15-22, GYUT-B 15- 30)
Zhejiang Geyi Medical Instrument Co., Ltd. · Decision date Sep 8, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 8, 2026 for K254294, a traditional 510(k) submitted by Zhejiang Geyi Medical Instrument Co., Ltd. of Jiande City, China, and received December 31, 2025. The device is a Single-use Digital Hysteroscope listed under twelve model designations spanning GYUT-A 12.6, GYUT-A 14.4 and GYUT-B 15 configurations. It falls under regulation 884.1690, product code HIH, in the Obstetrics/Gynecology specialty. SESE means clearance to market, not PMA approval.
The FDA review letter describes the intended use as viewing of the adult cervical canal and uterine cavity. The record does not identify a predicate device, summarize performance testing, or state the specific purpose beyond viewing; the excerpted letter text is truncated. The submission was not reviewed by a third party, is not a combination product, and no predetermined change control plan was authorized.
The public record does not include the full indications wording, the predicate comparison, or any clinical data, so the basis for the equivalence determination cannot be assessed from these sources.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Sep 8, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254294
- Regulatory pathway
- 510(k) premarket notification
- Product code
- HIH
- Decision code
- SESE
- Decision date
- Sep 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Hysteroscope (And Accessories).
- Product code
- HIH
- FDA device class
- 2
FDA decision timeline
K254294 received
Application receipt date recorded by FDA.
K254294 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Karl Storz SE & CO. KG | 510(k) clearance | Sep 25, 2026 | FDA | |
UNIDRIVE Select SystemK261102 | Karl Storz SE & CO. KG | 510(k) clearance | Sep 18, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zhejiang Geyi Medical Instrument Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Jiande City
Sources and methodology
- Original FDA record: K254294
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records